use disorder benefits, including supplemental benefits. (2) Determinations of medical necessity (A) In general Each MA organization shall ensure that any determination of medical necessity for mental health or substance use benefits under each MA plan offered by such organization that is not based on the application of a national or local coverage determination is consistent with generally accepted standards of mental health and substance use disorder care, as defined in paragraph. For any level of care determination with respect to mental health or substance use disorder benefits, coverage criteria are consistent with widely-used treatment guidelines only if they result in a level of care determination that is consistent with the determination that would have been made using the relevant widely-used treatment guidelines. (B) Criteria for medical necessity determinations The criteria for determination of medical necessity with respect to mental health or substance use disorder benefits under an MA plan shall be made available in plain language to any individual upon request. (3) Reporting on application of nonquantitative treatment limitations (A) Comparative analyses of design and application of nonquantitative treatment limits For 2025 and subsequent years, in the case of an MA organization that imposes nonquantitative treatment limitations (referred to in this paragraph as NQTLs ) on mental health or substance use disorder benefits under an MA plan offered by such organization, such organization shall be required to perform and document comparative analyses of the design and application of NQTLs on mental health and substance use disorder benefits under the plan and make available to the Secretary as provided under subparagraph (B), upon request, the comparative analyses and the following information: (i) The specific plan terms regarding the NQTLs and a description of all mental health or substance use disorder and medical benefits to which each such term applies in each respective benefits classification.